Technology-Enabled Patient and Physician Activation to Enhance Skin Cancer Screening After HCT: A Randomized Controlled Trial.
Technology helped transplant survivors get better skin cancer screening in a group with unusually high risk.
A technology-enabled RCT improved patient and physician activation for skin cancer screening in allogeneic hematopoietic cell transplant survivors, a population at elevated cancer surveillance risk. This record was retained from the prior triage attempt for PubMed pipeline handoff.
What the study was
- Study design
- rct
- Category
- Early Detection
- Maturity
- Potentially Practice-Changing
- Journal
- J Natl Compr Canc Netw
Why it surfaced
RCT in an actionable survivorship care gap with direct clinical applicability; HCT survivors have 2–5× elevated skin cancer risk; technology-enabled screening interventions can be rapidly adopted at transplant centers.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.